JP2001500850A5 - - Google Patents

Download PDF

Info

Publication number
JP2001500850A5
JP2001500850A5 JP1998510779A JP51077998A JP2001500850A5 JP 2001500850 A5 JP2001500850 A5 JP 2001500850A5 JP 1998510779 A JP1998510779 A JP 1998510779A JP 51077998 A JP51077998 A JP 51077998A JP 2001500850 A5 JP2001500850 A5 JP 2001500850A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP1998510779A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001500850A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/013871 external-priority patent/WO1998007718A1/en
Publication of JP2001500850A publication Critical patent/JP2001500850A/ja
Publication of JP2001500850A5 publication Critical patent/JP2001500850A5/ja
Abandoned legal-status Critical Current

Links

JP10510779A 1996-08-22 1997-08-06 非―ペプチドボンベシン受容体アンタゴニスト Abandoned JP2001500850A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2432396P 1996-08-22 1996-08-22
US60/024,323 1996-08-22
PCT/US1997/013871 WO1998007718A1 (en) 1996-08-22 1997-08-06 Non-peptide bombesin receptor antagonists

Publications (2)

Publication Number Publication Date
JP2001500850A JP2001500850A (ja) 2001-01-23
JP2001500850A5 true JP2001500850A5 (https=) 2005-04-07

Family

ID=21819999

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10510779A Abandoned JP2001500850A (ja) 1996-08-22 1997-08-06 非―ペプチドボンベシン受容体アンタゴニスト

Country Status (17)

Country Link
US (1) US6194437B1 (https=)
EP (1) EP0920424B1 (https=)
JP (1) JP2001500850A (https=)
AT (1) ATE311383T1 (https=)
AU (1) AU733226B2 (https=)
BR (1) BR9711342A (https=)
CA (1) CA2255966A1 (https=)
DE (1) DE69734773T2 (https=)
ES (1) ES2253782T3 (https=)
IL (1) IL127194A0 (https=)
IS (1) IS4937A (https=)
NO (1) NO312669B1 (https=)
NZ (1) NZ333038A (https=)
PL (1) PL331710A1 (https=)
TR (1) TR199900364T2 (https=)
WO (1) WO1998007718A1 (https=)
ZA (1) ZA977526B (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030069231A1 (en) * 1999-10-12 2003-04-10 Klaus Rudolf Modified aminoacids, pharmaceuticals containing these compounds and method for their production
US6518289B1 (en) * 1997-12-16 2003-02-11 Pfizer, Inc. 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
CA2355137A1 (en) 1998-12-18 2000-06-29 Martyn Clive Pritchard Non-peptide nk1 receptors antagonists
WO2000042023A1 (en) * 1999-01-18 2000-07-20 Novo Nordisk A/S Substituted imidazoles, their preparation and use
GB2369118A (en) * 2000-11-17 2002-05-22 Warner Lambert Co Bombesin receptor antagonists
AU2002223802A1 (en) * 2000-11-17 2002-05-27 Warner-Lambert Company Llc Treatment of sexual dysfunction with non peptide bombesin receptor antagonists
AU2001214046A1 (en) * 2000-11-17 2002-05-27 Warner-Lambert Company Llc Treatment of sexual dysfunction using bombesin antagonist
GB2369117A (en) * 2000-11-17 2002-05-22 Warner Lambert Co Bombesin receptor antagonists
CA2432066A1 (en) * 2000-12-20 2002-06-27 Robert Denham Pinnock Novel uses of non-peptide bombesin receptor antagonists for treating anxiety and panic disorders
ES2200617B1 (es) * 2001-01-19 2005-05-01 Almirall Prodesfarma, S.A. Derivados de urea como antagonistas de integrinas alfa 4.
DE10123163A1 (de) 2001-05-09 2003-01-16 Gruenenthal Gmbh Substituierte Cyclohexan-1,4-diaminderivate
US20030031627A1 (en) * 2001-07-31 2003-02-13 Mallinckrodt Inc. Internal image antibodies for optical imaging and therapy
US8612005B2 (en) * 2002-02-01 2013-12-17 The Cleveland Clinic Foundation Neurostimulation for affecting sleep disorders
CA2484582A1 (en) * 2002-05-03 2003-11-13 Warner-Lambert Company Llc Bombesin antagonists
US7244743B2 (en) 2002-06-05 2007-07-17 Solvay Pharmaceuticals Gmbh Non-peptidic BRS-3 agonists
BR0314219A (pt) * 2002-09-11 2005-07-19 Warner Lambert Co Inibidores do fator xa e outras serina proteases envolvidas na cascata da coagulação
US7595312B2 (en) * 2002-10-25 2009-09-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
US6846836B2 (en) * 2003-04-18 2005-01-25 Bristol-Myers Squibb Company N-substituted phenylurea inhibitors of mitochondrial F1F0 ATP hydrolase
GB0403578D0 (en) * 2004-02-18 2004-03-24 Biofocus Discovery Ltd Compounds which interact with the G-protein coupled receptor family
DE102004015723A1 (de) 2004-03-29 2005-10-20 Boehringer Ingelheim Pharma Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
US7795385B2 (en) * 2004-12-17 2010-09-14 Bexar Global, Inc. Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
WO2006115135A1 (ja) * 2005-04-21 2006-11-02 Astellas Pharma Inc. 過敏性腸症候群治療剤
BRPI0706365A2 (pt) * 2006-01-06 2011-03-22 Sepracor Inc Cicloalquilaminas como inibidores da recaptação de monoamina
JPWO2015152128A1 (ja) * 2014-03-31 2017-04-13 長瀬産業株式会社 アミノ酸前駆体、アミノ酸およびその製造方法、ならびに該アミノ酸を用いたpet診断用トレーサー
CN105884674B (zh) * 2015-01-05 2019-07-26 南开大学 色氨酸衍生物及制备方法和在防治植物病毒、杀菌、杀虫方面的应用
GB2561540A (en) * 2017-03-13 2018-10-24 Nodthera Ltd Chemical compounds

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000297A (en) 1971-05-18 1976-12-28 Rotta Research Laboratorium S.P.A. N-p-chlorobenzoyl tryptophane, salts and compositions thereof
EP0107735B1 (en) 1981-10-20 1988-10-19 Mitsui Toatsu Kagaku Kabushiki Kaisha Novel pyridazinone derivatives
FR2546517B1 (fr) 1983-05-24 1987-04-24 Panmedica Nouveaux dipeptides du -l-5-hydroxy-tryptophane, procedes pour leur preparation et medicaments les contenant
EP0288965A2 (de) 1987-04-29 1988-11-02 Hoechst Aktiengesellschaft Peptide mit Phospholipase A2- hemmender Wirkung
US5378803A (en) 1987-12-11 1995-01-03 Sterling Winthrop Inc. Azole-fused peptides and processes for preparation thereof
US5346907A (en) 1988-04-05 1994-09-13 Abbott Laboratories Amino acid analog CCK antagonists
US5153226A (en) * 1989-08-31 1992-10-06 Warner-Lambert Company Acat inhibitors for treating hypocholesterolemia
AU687754B2 (en) * 1990-08-31 1998-03-05 Warner-Lambert Company Tachykinin antagonists
NZ239595A (en) 1990-08-31 1994-06-27 Warner Lambert Co Cholecystokinin antagonistic compounds ; pharmaceutical compositions and use thereof
JPH06509332A (ja) 1991-07-05 1994-10-20 メルク シヤープ エンド ドーム リミテツド 芳香族化合物、それらを含む医薬組成物、及び治療におけるそれらの使用
US5472978A (en) 1991-07-05 1995-12-05 Merck Sharp & Dohme Ltd. Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
WO1993001165A2 (en) 1991-07-10 1993-01-21 Merck Sharp & Dohme Limited Aromatic compounds, compositions containing them and their use in therapy
US5495047A (en) 1991-07-10 1996-02-27 Merck, Sharp & Dohme (Ltd.) Fused tricyclic compounds, pharmaceutical compositions containing them and their use in therapy
FR2687147A1 (fr) * 1992-02-11 1993-08-13 Union Pharma Scient Appl Nouveaux derives d'alpha-amino n-pyridyl benzene propanamide, leurs procedes de preparation, compositions pharmaceutiques les contenant.
AU4028393A (en) 1992-05-28 1993-12-30 Pfizer Inc. New (N)-aryl and (N)-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (ACAT)
US5340798A (en) 1992-10-14 1994-08-23 Merck & Co., Inc. Fibrinogen receptor antagonists
US5534529A (en) 1993-06-30 1996-07-09 Sankyo Company, Limited Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
JPH07101929A (ja) 1993-10-01 1995-04-18 Fujisawa Pharmaceut Co Ltd 尿素誘導体およびその製造法
US5455262A (en) 1993-10-06 1995-10-03 Florida State University Mercaptosulfide metalloproteinase inhibitors
US5470834A (en) 1993-10-06 1995-11-28 Florida State University Sulfoximine and suldodiimine matrix metalloproteinase inhibitors

Similar Documents

Publication Publication Date Title
JP2000502280A5 (https=)
JP2000501771A5 (https=)
JP2000514474A5 (https=)
JP2001501104A5 (https=)
JP2000501599A5 (https=)
JP2001516230A5 (https=)
JP2001509135A5 (https=)
JP2001502005A5 (https=)
JP2000502472A5 (https=)
JP2000501825A5 (https=)
JP2000515510A5 (https=)
JP2002500619A5 (https=)
JP2000502485A5 (https=)
JP2000502425A5 (https=)
JP2000502568A5 (https=)
JP2000501774A5 (https=)
JP2000502570A5 (https=)
JP2001507180A5 (https=)
JP2000501876A5 (https=)
JP2001504107A5 (https=)
JP2000513976A5 (https=)
JP2000501744A5 (https=)
JP2000502316A5 (https=)
JP2000502714A5 (https=)
JP2000501569A5 (https=)